ZA93275B - Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them. - Google Patents

Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them.

Info

Publication number
ZA93275B
ZA93275B ZA93275A ZA93275A ZA93275B ZA 93275 B ZA93275 B ZA 93275B ZA 93275 A ZA93275 A ZA 93275A ZA 93275 A ZA93275 A ZA 93275A ZA 93275 B ZA93275 B ZA 93275B
Authority
ZA
South Africa
Prior art keywords
bradykinin
preparing
pharmaceutical compositions
compositions containing
antagonist activity
Prior art date
Application number
ZA93275A
Other languages
English (en)
Inventor
Jean-Luc Fauchere
Christophe Thurieau
Emmanuel Canet
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA93275B publication Critical patent/ZA93275B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA93275A 1992-01-17 1993-01-15 Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them. ZA93275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200438A FR2686343B1 (fr) 1992-01-17 1992-01-17 Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA93275B true ZA93275B (en) 1993-08-23

Family

ID=9425706

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93275A ZA93275B (en) 1992-01-17 1993-01-15 Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them.

Country Status (13)

Country Link
US (1) US5409899A (de)
EP (1) EP0552106B1 (de)
JP (1) JPH0730112B2 (de)
AT (1) ATE133960T1 (de)
AU (1) AU653460B2 (de)
CA (1) CA2087379A1 (de)
DE (1) DE69301468T2 (de)
DK (1) DK0552106T3 (de)
ES (1) ES2086195T3 (de)
FR (1) FR2686343B1 (de)
GR (1) GR3019372T3 (de)
NZ (1) NZ245685A (de)
ZA (1) ZA93275B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE69627191T2 (de) * 1995-06-09 2004-01-08 The Regents Of The University Of Michigan, Ann Arbor Bradikininanaloge als selektive thrombininhibitoren
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE370453C (de) * 1923-03-03 Franz Puening Destillationsverfahren
JPS507057B1 (de) * 1970-10-28 1975-03-20

Also Published As

Publication number Publication date
CA2087379A1 (fr) 1993-07-18
FR2686343B1 (fr) 1994-03-11
DE69301468T2 (de) 1996-09-05
DK0552106T3 (da) 1996-06-24
AU653460B2 (en) 1994-09-29
ATE133960T1 (de) 1996-02-15
NZ245685A (en) 1994-07-26
AU3184493A (en) 1993-07-22
DE69301468D1 (de) 1996-03-21
EP0552106B1 (de) 1996-02-07
EP0552106A1 (de) 1993-07-21
US5409899A (en) 1995-04-25
GR3019372T3 (en) 1996-06-30
ES2086195T3 (es) 1996-06-16
JPH06179697A (ja) 1994-06-28
JPH0730112B2 (ja) 1995-04-05
FR2686343A1 (fr) 1993-07-23

Similar Documents

Publication Publication Date Title
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
GB2364304A (en) Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
ATE152910T1 (de) Verwendung von taxol zur herstellung eines arzneimittels zur behandlung von krebs
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
HU913193D0 (en) 17betha-substituted 4-aza-5alpha-androstane-3-on derivatives, process for their production and for the production of medical preparations containing them
HUT54705A (en) Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same
AU661591B2 (en) 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
ZA93275B (en) Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them.
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
NZ215480A (en) Polyprenyl compounds and compositions
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
GEP20022613B (en) Compositions with Beneficial Organoleptic Properties and Their Solvates, Method for Their Production and Pharmaceutical Compound Containing the Same
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
EP0551844A3 (de)
IL79279A0 (en) Pharmaceutical composition for the treatment of tumors containing the reaction product of a cytotoxic aldehyde with penicillamine
HUT55341A (en) Process for producing vanillic acid alkyl esters, pharmaceutical compositions comprising same, as well as biocidal preparations containing vanillic acid alkyl esters
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.